Tiny cell fragments may explain clot danger in Kids' leukemia treatment
NCT ID NCT02862652
First seen Jan 21, 2026 · Last updated May 14, 2026 · Updated 18 times
Summary
This study looked at 24 children with acute lymphoblastic leukemia to understand why blood clots form during early treatment. Researchers measured tiny cell fragments called microparticles, which can trigger clotting. The goal was to see if these fragments contribute to the increased clot risk, since current prevention methods are not fully effective.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chu de Reims
Reims, 51092, France
Conditions
Explore the condition pages connected to this study.